Humana's Income Statement Analysis: Revenue to Profit Breakdown
Humana's Income Statement Analysis: Revenue to Profit Breakdown
|
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$83.06 B | $92.87 B | $106.37 B | $117.76 B | $129.66 B | $145.68 B |
|
Cost of Revenue Direct cost of goods/services. |
|
- | - | - | - | $110.81 B | $125.79 B |
Gross Profit Revenue minus cost of revenue. |
|
$83.06 B | $92.87 B | $106.37 B | $117.76 B | $18.85 B | $19.89 B |
|
Operating Expense
Costs to run business. |
|
$79.71 B | $89.30 B | $102.99 B | $116.04 B | $17.40 B | $17.87 B |
Research and Development Investment in innovation. |
|
- | - | - | - | - | - |
|
Sales, General and Administrative
Selling and admin costs. |
|
- | - | - | - | - | $3.98 B |
General and Administrative Corporate overhead costs. |
|
- | - | - | - | - | $3.98 B |
Sales and Marketing Customer acquisition costs. |
|
- | - | - | - | - | - |
Other Expenses Other operating costs. |
|
$79.71 B | $89.30 B | $102.99 B | $116.04 B | $17.40 B | $13.89 B |
Operating Income Profit from operations. |
|
$3.35 B | $3.57 B | $3.38 B | $1.72 B | $1.45 B | $2.02 B |
|
Net Interest Income
Interest income minus expense. |
|
-$326.00 M | -$401.00 M | -$493.00 M | -$660.00 M | -$631.00 M | -$704.00 M |
Interest Income Income from investments. |
|
- | - | - | - | - | - |
Interest Expense Cost of borrowing. |
|
$326.00 M | $401.00 M | $493.00 M | $660.00 M | $631.00 M | $704.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$326.00 M | -$401.00 M | -$493.00 M | -$660.00 M | -$631.00 M | -$296.00 M |
Total Other Income (Net) Net non-operating items. |
|
- | - | - | - | - | -$408.00 M |
Income Before Tax Profit before taxes. |
|
$3.35 B | $3.57 B | $3.38 B | $1.72 B | $1.45 B | $1.61 B |
Income Tax Expense Taxes on income. |
|
$485.00 M | $762.00 M | $836.00 M | $413.00 M | $250.00 M | $298.00 M |
|
Net Income
Final profit. |
|
$2.93 B | $2.81 B | $2.49 B | $1.21 B | $1.19 B | $1.28 B |
Net Income From Continuing Operations Profit from core business. |
|
$2.93 B | $2.80 B | $2.48 B | $1.21 B | $1.20 B | $1.32 B |
Net Income From Discontinued Operations Profit/loss from sold units. |
|
- | - | - | - | - | - |
Other Adjustments to Net Income Additional accounting adjustments. |
|
- | - | - | - | - | -$20.00 M |
Net Income Deductions Reductions from net income. |
|
- | - | - | - | - | - |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$22.79 | $22.20 | $20.09 | $10.01 | $9.87 | $10.65 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$22.67 | $22.08 | $20.00 | $9.98 | $9.84 | $10.56 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
128.69 M | 126.42 M | 123.87 M | 120.57 M | 120.45 M | 120.20 M |
Diluted Average Shares Outst. Shares including dilution. |
|
129.40 M | 127.09 M | 124.44 M | 120.87 M | 120.83 M | 120.89 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$3.68 B | $3.97 B | $3.88 B | $2.38 B | $2.08 B | $2.32 B |
EBITDA Earnings before interest, tax, D&A. |
|
$4.39 B | $4.81 B | $4.79 B | $3.35 B | $2.91 B | $3.07 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$713.00 M | $845.00 M | $917.00 M | $968.00 M | $824.00 M | $751.00 M |
| Company Report |
Humana's Assets vs Liabilities & Equity
| Loading balance sheet when needed... |
| Loading cash flow statement when needed... |
| Loading profitability metrics when needed... |
Data sources and methodology
| Last updated | Jun 30, 2026 |
| Latest financial periods ended |
Quarterly: Q2 FY2026 (June 30, 2026) Annual: FY 2025 (December 31, 2025) |
| Data provided by | Financial Modeling Prep |
| Original source | Company Forms 10-Q and 10-K filed with the SEC |
| Methodology | Company-reported financial statements and calculated financial ratios |
| Limitations | Historical values may change because of company restatements, reclassifications, or provider updates |
| Links | View source filings |




